ArticleCurrent medical science2026
LATS1/2 Inhibitor Attenuates Osteoclast Differentiation via Hippo-YAP/TAZ Signaling Pathway and Alleviates Osteoporosis in Ovariectomized Rats.
Si-Hui Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.